Farmak discovers and delivers innovative medicines and solutions that enhance people’s lives.
We continually expand our market presence in well-regulated and emerging markets by developing and producing high-quality products and maintaining a robust business reputation.
Film-coated Tablets
75mg, 150mg
75mg
Solution for Injection
2000 anti-Xa IU: 0.2mL 4000 anti-Xa IU: 0.4mL 6000 anti-Xa IU: 0.6mL 8000 anti-Xa IU: 0.8mL
30 000 anti-Xa IU: 3mL
50mg iron/mL: 2mL, 10mL, 20mL
2.5mg/0.5mL: 0.5mL
Film-coated Tablets Solution for Injection
500mg
100mg/mL: 5mL, 10mL
Farmak International offers medications developed to treat conditions related to issues with blood and blood-forming organs. Being a thromboprophylaxis supplier, we are mostly focused on thrombosis prevention. Additionally, we offer products for bleeding management.
As a blood modifier and cardiovascular medications distributor, Farmak International offers a comprehensive coagulation and hemostasis product portfolio. We develop and produce solutions that can be split into the following categories:
In addition to procoagulants and VTE prevention medications, we offer Ferric carboxymaltose to treat bleeding-induced anemia in patients who cannot benefit from oral iron for any reason. It is also used to improve exercise ability in adults with chronic heart failure.
The global thrombosis and hemostasis market is highly dependent on active ingredients, making institutional anticoagulation supply vulnerable to disruptions. Farmak International successfully contributes to preventing critical shortages that can affect patient care, as a Factor Xa inhibitors, antifibrinolytic, and antiplatelet drugs distributor.
Our products are used in healthcare for diagnosing, treating, or preventing disease in patients. We specify the medical indications, correct dosages, and methods of administration for specific conditions, including:
Our medications can also be used for post-surgical thromboprophylaxis and included in hospital anticoagulation protocols.
To ensure accurate dosing, reduce waste, and enable safe, convenient administration, injectable anticoagulant suppliers typically package medication in prefilled syringes or vials. Vials are mostly used for flexible adjustments by physicians, while prefilled syringes are convenient to be used by patients from home without the risk of dosing errors. In our CTD-ready portfolio, there are also oral antiplatelet and hemostatic agents designed in film-coated tablets with multiple dosage strengths for weight-based dosing.
Any hospital anticoagulation options from the above list are a ready-to-use presentation for hospital convenience, being accurately pre-measured and labeled. There is no need for blending or dilution, which enhances pharmacy workflow. We strictly adhere to storage requirements. Our storage capacity is properly designed and equipped to remove environmental factors that can cause chemical degradation and physical breakdown of medications.
To ensure high quality and safety of our products, we hold EU GMP certifications that prove our manufacturing facilities in Ukraine and Spain consistently meet the strictest hygiene and safety standards. As an acetylsalicylic acid, clopidogrel, enoxaparin, ferric carboxymaltose, and fondaparinux supplier in Europe, we accurately document the supply chain and test batches.
To achieve pharmacopoeia compliance for anti-Xa activity testing, we ensure that anticoagulant drugs meet globally standardised quality control and potency specifications. As a generic drug manufacturer, we develop complete regulatory dossiers (CTD, EU CTD) to sell our products to institutional distributors or healthcare procurement organisations, who will deliver them to B2B customers, such as anticoagulants supplier hospitals or directly to hospital networks. When needed, we are ready to render support for hospital anticoagulation protocols.
We provide reliable supply for hospital anticoagulation programs and offer flexible packaging options. Whatever is preferred by our partners, whether prefilled syringe anticoagulants, vials, or film-coated tablets, we are ready to deliver our medications to Europe, the MENA region, and Central Asia.
We provide documents for tender submissions and technical support, if needed. Inclusion in institutional formularies is critical for any drug manufacturer. To position our drugs as the standard of care and increase sales volumes, we always offer competitive pricing.
This information is intended solely for healthcare professionals. Healthcare professionals must rely on their own professional clinical judgment when deciding whether to use a particular product for treating a specific patient. Farmak AG does not provide medical advice and recommends that healthcare professionals be appropriately trained in the use of any product before administering it. Healthcare professionals must always refer to the product's package insert, label, and/or instructions for use before application. The information provided is intended to illustrate Farmak AG's product portfolio and may vary depending on regulatory or medical practices in different markets. Please contact your local Farmak International representative for availability information about specific products in your area.
This page is designed exclusively for healthcare professionals. If you are not a healthcare professional, please return to our homepage for general information about Farmak International.
Please check your email inbox for our corporate materials.
Please fill all the fields marked by *